iShares Trust - iShares U.S. Medical Devices ETF
GB ˙ LSE ˙ US4642888105
53,11 $ ↑0,08 (0,15%)
2023-12-18
DEL PRIS
SecurityGB:0JJJ / iShares Trust - iShares U.S. Medical Devices ETF
InstitutionSummit Trail Advisors, Llc
Latest Disclosed Ownership10,821 shares
Latest Disclosed Value $ 577,300
Summit Trail Advisors, Llc ownership in 0JJJ / iShares Trust - iShares U.S. Medical Devices ETF

On May 12, 2026 - Summit Trail Advisors, Llc filed a 13F-HR form disclosing ownership of 10,821 shares of iShares Trust - iShares U.S. Medical Devices ETF (GB:0JJJ) valued at $577,300 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 10,821 shares of iShares Trust - iShares U.S. Medical Devices ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $574,703 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ISHARES TR U.S. MED DVC ETF 464288810 10,821 0 0.00 577 -14.14 0.0083
2026-02-17 2025-12-31 13F ISHARES TR U.S. MED DVC ETF 464288810 10,821 0 0.00 673 3.38 0.0116
2025-11-14 2025-09-30 13F ISHARES TR U.S. MED DVC ETF 464288810 10,821 0 0.00 650 -3.99 0.0090
2025-08-14 2025-06-30 13F ISHARES TR U.S. MED DVC ETF 464288810 10,821 10,821 678 0.0116
2025-01-29 2024-12-31 13F ISHARES TR U.S. MED DVC ETF 464288810 0 -14,866 -100.00 0 -100.00
2024-11-12 2024-09-30 13F ISHARES TR U.S. MED DVC ETF 464288810 14,866 0 0.00 880 5.64 0.0218
2024-08-13 2024-06-30 13F iShares U.S. Medical Devices ETF U.S. MED DVC ETF 464288810 14,866 0 0.00 833 -4.25 0.0219
2024-04-23 2024-03-31 13F ISHARES TR U.S. MED DVC ETF 464288810 14,866 0 0.00 871 8.48 0.0232
2024-02-06 2023-12-31 13F ISHARES TR U.S. MED DVC ETF 464288810 14,866 0 0.00 802 11.08 0.0265
2023-10-30 2023-09-30 13F ISHARES TR U.S. MED DVC ETF 464288810 14,866 0 0.00 723 -13.95 0.0266
2023-07-25 2023-06-30 13F ISHARES TR U.S. MED DVC ETF 464288810 14,866 0 0.00 839 4.61 0.0317
2023-05-04 2023-03-31 13F ISHARES TR U.S. MED DVC ETF 464288810 14,866 14,866 802 0.0323
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.